Watch how Labyrinth One transforms routine blood samples into high-quality circulating tumor cells through a fully automated, plug-and-play workflow.
Automated, label-free microfluidic separation
High throughput and clinical scalability
Preserves live, intact cells for downstream assays
STEP 1
A standard blood draw — just 7–10 mL — is all it takes. Within minutes, the sample is processed through the Labyrinth One microfluidic cartridge, no labels or reagents required.
STEP 2
Our patented Labyrinth microfluidic chip uses intricate channel geometry to create precise fluidic dynamics. These natural flow patterns separate circulating tumor cells (CTCs) from billions of normal blood cells — purely based on size, shape, and deformability.
STEP 3
The isolated CTCs remain intact and viable, ready for a wide range of analyses —
from immunostaining and FISH to single-cell sequencing, organoid culture, and drug testing.
